New drugs in multiple myeloma - role of carfilzomib and pomalidomide.

Jurczyszyn, Artur; Legiec, Wojciech; Helbig, Grzegorz; Hus, Marek; Kyrcz-Krzemien, Slawomira; Skotnicki, Aleksander B

Jurczyszyn, Artur; Legiec, Wojciech; Helbig, Grzegorz; Hus, Marek; Kyrcz-Krzemien, Slawomira; Skotnicki, Aleksander B.

Afiliación

Jurczyszyn A; Department of Hematology, Krakow University Hospital, Poland.
Legiec W; Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Poland.
Helbig G; Department of Hematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland.
Hus M; Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Poland.
Kyrcz-Krzemien S; Department of Hematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland.
Skotnicki AB; Chair and Department of Hematology, Jagiellonian University Medical College, Krakow, Poland.

Contemp Oncol (Pozn) ; 18(1): 17-21, 2014.

Article en En | MEDLINE | ID: mdl-24876816

Palabras clave

carfilzomib; multiple myeloma; pomalidomide; treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Contemp Oncol (Pozn) Año: 2014 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Polonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google